In conclusion, in this follow-up study of 9-year-old offspring of mothers with GDM randomized to metformin or insulin treatment during pregnancy, we found that metformin did not adversely affect either offspring's neurocognitive outcomes assessed by standardized tests or executive function assessed by teachers and parents. Here, INS is linked to gestational diabetes.